Review of updated clinical practice guidelines of the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) for Clostridium difficile infection in adults and children (2017)

Kozlov, Roman; Shelygin, Yu. A.; Веселов, А В; Дехнич, А В; Зубарева, Н А; Ершова, О Н; Кулабухов, В. В.; Popov, D. A.; Reshedko, G. K.; Yakushin, Sergey Borisovich

doi:10.36488/cmac.2018.2.76-124

Cited by 2 publications

(2 citation statements)

References 361 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…6 ФГБНУ «Научно-исследовательский институт медицины труда имени академика Н. Ф. Измерова», 105275, Россия, Москва, проспект Буденного, д. 31 7 Федеральное государственное автономное образовательное учреждение высшего образования «Российский университет дружбы народов» (РУДН), 117198, Россия, Москва, ул. Миклухо-Маклая, д.…”

Section: клинические рекомендации Clinical Guidelinesunclassified

“…Факторы риска клостридиальной инфекции [5][6][7][8] По данным ряда эпидемиологических исследований, с 2020 г. по 2022 г. заболеваемость CDI в стационарах оставалась стабильной или наблюдалось её снижение, что связывают с улучшением санитарно-противоэпидемических мероприятий [17,18]. Однако, в работе Bentivegna E. с соавторами (2021) показана тенденция к более высокой заболеваемости CDI в отделениях для лечения новой коронавирусной инфекции в сравнении с другими отделениями [19]…”

Section: таблицаunclassified

See 1 more Smart Citation

<i>Clostridioides difficile</i> infection: diagnosis, treatment, and prevention Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North- West Society of Gastroenterologists and Hepatologists

Drapkina¹,

Лазебник

Бакулин

et al. 2023

jour

View full text Add to dashboard Cite

Clostridioides difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea, and an important cause of nosocomial infection. Since the publication of the National Guidelines (2016, 2017), new data have been accumulated on the genetic structure and pathogenic properties of the most common causative agent of severe forms of antibiotic- associated diarrhea, which has led to the reclassifi cation of the pathogen, formerly known as Clostridium diffi cile, to Clostridioides difficile. Laboratory algorithms have been developed to diagnose CDI and determine the toxigenicity of strains reliably. New data on the effectiveness of antibacterials have been published, monoclonal antibodies to toxin B (bezlotoxumab) have been introduced into clinical practice to prevent CDI recurrence, and fecal microbiota transplantation has been proposed. Over the past 5 years, many international guidelines on the management of adult patients with CDI have also been updated (USA, EU). In the last decade, including due to the COVID-19 pandemic, there has been an increase in CDI incidence. Considering therelevance of CDI, new data on the pathogen, and domestic features, the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North-West Society of Gastroenterologists and Hepatologists developed these clinical guidelines.

show abstract

Section: клинические рекомендации Clinical Guidelinesunclassified

Section: таблицаunclassified

<i>Clostridioides difficile</i> infection: diagnosis, treatment, and prevention Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North- West Society of Gastroenterologists and Hepatologists

Drapkina¹,

Лазебник

Бакулин

et al. 2023

jour

View full text Add to dashboard Cite

show abstract

Severe Clostridium diffi cile infection after liver and kidney transplantation

Кокина

Малиновская

Sidorenko

et al. 2019

Transplantologiâ (Mosk.)

View full text Add to dashboard Cite

Recent statistics have shown increased rates of morbidity and mortality from Clostridium difficile infection worldwide. This problem is mainly typical for surgical patients and is associated with an antibiotic therapy and a prolonged hospital stay. Recipients of solid organs are at a high risk of developing severe forms of C. difficile infection due to immunosupression. Existing recommendations for the treatment of C. difficile infection are based on the severity of the disease and do not consider patients after liver transplantation. The aim of this work is to determine an actual tactics for the diagnosis and treatment of C. difficile in organ recipients in clinical practice.

show abstract

Review of updated clinical practice guidelines of the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) for Clostridium difficile infection in adults and children (2017)

Cited by 2 publications

References 361 publications

<i>Clostridioides difficile</i> infection: diagnosis, treatment, and prevention Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North- West Society of Gastroenterologists and Hepatologists

<i>Clostridioides difficile</i> infection: diagnosis, treatment, and prevention Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North- West Society of Gastroenterologists and Hepatologists

Severe Clostridium diffi cile infection after liver and kidney transplantation

Contact Info

Product

Resources

About